Cargando…
Inhibition of Mitochondrial Redox Signaling with MitoQ Prevents Metastasis of Human Pancreatic Cancer in Mice
SIMPLE SUMMARY: If improvements of diagnostic techniques and methodologies allow to increasingly detect cancers at the premetastatic stage, metastases still account for about 90% of cancer patient deaths in the clinics. Indeed, there is currently no specific treatment capable of blocking or even del...
Autores principales: | Capeloa, Tania, Van de Velde, Justine A., d’Hose, Donatienne, Lipari, Sara G., Derouane, Françoise, Hamelin, Loïc, Bedin, Marie, Vazeille, Thibaut, Duhoux, François P., Murphy, Michael P., Porporato, Paolo E., Gallez, Bernard, Sonveaux, Pierre |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9562676/ https://www.ncbi.nlm.nih.gov/pubmed/36230841 http://dx.doi.org/10.3390/cancers14194918 |
Ejemplares similares
-
MitoQ Inhibits Human Breast Cancer Cell Migration, Invasion and Clonogenicity
por: Capeloa, Tania, et al.
Publicado: (2022) -
MitoQ Prevents Human Breast Cancer Recurrence and Lung Metastasis in Mice †
por: Capeloa, Tania, et al.
Publicado: (2022) -
Statins Alleviate Tumor Hypoxia in Prostate Cancer Models by Decreasing Oxygen Consumption: An Opportunity for Radiosensitization?
por: d’Hose, Donatienne, et al.
Publicado: (2022) -
EPR Investigations to Study the Impact of Mito-Metformin on the Mitochondrial Function of Prostate Cancer Cells
por: d’Hose, Donatienne, et al.
Publicado: (2022) -
In Vitro and In Vivo Characterization of MCT1 Inhibitor AZD3965 Confirms Preclinical Safety Compatible with Breast Cancer Treatment
por: Benyahia, Zohra, et al.
Publicado: (2021)